Category - Pharma Industry News
bluebird bio provides update on 2seventy bio spin-off
Amgen reveals new combination data for KRAS inhibitor
GSK plans UK headquarters for new consumer healthcare company
AZ’s long-acting antibody combo shows benefit in COVID-19 trial
Results of AstraZeneca’s TACKLE phase 3 trial show antibody combination reduces risk of severe COVID-19 or death
Sandoz completes acquisition of GSK’s cephalosporin business
UK pharmacy M&A transactions up by 26%
COVID-19 vaccine trial participants to be offered additional doses